Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms

• Main Authors: Yanfang Yang (Author), Ke Feng (Author), Liying Yuan (Author), Yuxin Liu (Author), Mengying Zhang (Author), Kaimin Guo (Author), Zequn Yin (Author), Wenjia Wang (Author), Shuiping Zhou (Author), He Sun (Author), Kaijing Yan (Author), Xijun Yan (Author), Xuerui Wang (Author), Yajun Duan (Author), Yunhui Hu (Author), Jihong Han (Author)
• Format: Book
• Published: Elsevier, 2023-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Heart failure is the leading cause of death worldwide. Compound Danshen Dripping Pill (CDDP) or CDDP combined with simvastatin has been widely used to treat patients with myocardial infarction and other cardiovascular diseases in China. However, the effect of CDDP on hypercholesterolemia/atheroscler...